Impact of prophylaxis, inhibitors, and genetics on joint outcomes according to the IPSG-MRI score in hemophilia A, B and vWD type 3

Key Points

• Reduced joint damage correlates with early diagnosis and therapy adherence for hemophilia and vWD.
• The IPSG score effectively assesses and monitors joint health in patients with bleeding disorders.
• Assessment highlights the importance of consistent prophylaxis in preventing joint deterioration over time.
• Findings suggest proactive management strategies can significantly improve quality of life for affected patients.